stocks logo

SKIN

Beauty Health Co
$
1.590
-0.07(-4.217%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.690
Open
1.690
VWAP
1.61
Vol
466.44K
Mkt Cap
200.36M
Low
1.590
Amount
750.93K
EV/EBITDA(TTM)
--
Total Shares
123.63M
EV
380.31M
EV/OCF(TTM)
10.57
P/S(TTM)
0.61
The Beauty Health Company is a medical technology meets beauty company that delivers skin-health experiences. The Company and its subsidiaries design, develop, manufacture, market, and sell esthetic technologies and products. It specializes in skin health for all ages, genders, skin tones, and skin types. Its brands include Hydrafacial, SkinStylus, and Keravive. Hydrafacial created the category of hydradermabrasion with its patented delivery system that cleanses, extracts, and hydrates the skin with proprietary solutions and serums. SkinStylus specializes in nanoneedling and microneedling, where its products are designed to provide either a non-invasive (nanoneedling) or minimally invasive (microneedling) skin treatment to individuals. Keravive specializes in scalp health with its products that are designed to support the hair’s natural growth by cleansing, exfoliating, and hydrating the scalp and hair follicles.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
74.00M
-18.32%
0.020
-75.52%
69.28M
-12.08%
-0.010
-122.99%
77.00M
-7.78%
0.020
-200%
Estimates Revision
The market is revising Upward the revenue expectations for The Beauty Health Company (SKIN) for FY2025, with the revenue forecasts being adjusted by 2.23% over the past three months. During the same period, the stock price has changed by 93.60%.
Revenue Estimates for FY2025
Revise Upward
up Image
+2.23%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-83.33%
In Past 3 Month
Stock Price
Go Up
up Image
+93.60%
In Past 3 Month
5 Analyst Rating
down Image
-1.89% Downside
Wall Street analysts forecast SKIN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SKIN is 1.56 USD with a low forecast of 1.00 USD and a high forecast of 2.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
4 Hold
1 Sell
Hold
down Image
-1.89% Downside
Current: 1.590
sliders
Low
1.00
Averages
1.56
High
2.00
TD Cowen
Oliver Chen
Hold
maintain
$2
2025-05-12
Reason
TD Cowen analyst Oliver Chen raised the firm's price target on Beauty Health to $2 from $1.50 and keeps a Hold rating on the shares. The firm noted Q1 sales declined but management is cautious due to macro and lowered expectations for the remainder of FY25.Cowen views the updated FY25 guide as conservative, but APAC and tariffs remain key pressure points.
Canaccord Genuity
Susan Anderson
Hold
Maintains
$1.75 → $1.5
2025-03-13
Reason
Canaccord lowered the firm's price target on Beauty Health to $1.50 from $1.75 and keeps a Hold rating on the shares. The firm said they reported Q4 sales were lower and although the high- margin consumables business continues to perform well, we continue to see new machine placements severely pressured due to macro conditions.
Canaccord Genuity
Susan Anderson
Hold
Maintains
$1.25 → $1.75
2024-11-13
Reason
Canaccord raised the firm's price target on Beauty Health to $1.75 from $1.25 and keeps a Hold rating on the shares. The firm said the company has continued to see strong demand for the consumables business, with sales up around +10% while macro conditions have impacted new machine placements, leading to roughly 46% year-over-year decline in delivery system revenue.
Canaccord Genuity
Susan Anderson
Hold
Maintains
$2 → $1.25
2024-08-12
Reason
Piper Sandler
Korinne Wolfmeyer
Sell
Reiterates
$1.5 → $1
2024-08-09
Reason
Stifel
Jonathan Block
Hold
Maintains
$4 → $2
2024-07-26
Reason

Valuation Metrics

The current forward P/E ratio for Beauty Health Co (SKIN.O) is -636.00, compared to its 5-year average forward P/E of 54.35. For a more detailed relative valuation and DCF analysis to assess Beauty Health Co 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
54.35
Current PE
-636.00
Overvalued PE
246.43
Undervalued PE
-137.74

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
38.57
Current EV/EBITDA
20.67
Overvalued EV/EBITDA
84.65
Undervalued EV/EBITDA
-7.51

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
3.75
Current PS
0.72
Overvalued PS
7.43
Undervalued PS
0.07

Financials

Annual
Quarterly
FY2025Q1
YoY :
-14.52%
69.58M
Total Revenue
FY2025Q1
YoY :
-29.24%
-12.02M
Operating Profit
FY2025Q1
YoY :
+1386.89%
-10.10M
Net Income after Tax
FY2025Q1
YoY :
+700.00%
-0.08
EPS - Diluted
FY2025Q1
YoY :
-109.92%
1.85M
Free Cash Flow
FY2025Q1
YoY :
+17.52%
69.82
Gross Profit Margin - %
FY2025Q1
YoY :
+365.33%
9.26
FCF Margin - %
FY2025Q1
YoY :
+1648.19%
-14.51
Net Margin - %
FY2025Q1
N/A
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
22.0K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
1
43.7K
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 87233.33% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

SKIN News & Events

Events Timeline

2025-06-10 (ET)
2025-06-10
08:18:12
Beauty Health launches Hydrafacial HydraFillic with Pep9 Booster
select
2025-06-04 (ET)
2025-06-04
08:13:03
Beauty Health surpasses 35,000 Hydrafacial devices install worldwide
select
2025-05-21 (ET)
2025-05-21
08:06:36
Beauty Health announces convertible debt refinancing
select
Sign Up For More Events

News

5.0
06-10Newsfilter
Hydrafacial Unveils New HydraFillic with Pep9™ Skin Booster For Fine Line & Wrinkles
5.0
06-04Newsfilter
BeautyHealth Surpasses 35,000 Hydrafacial Devices Worldwide Reflecting Growing Consumer Demand for Clinically Proven Skin Health Treatments
8.5
05-21Benzinga
Bitcoin Bull Anthony Pompliano Launches SPAC Targeting Financial Services: 'My Reputation's On This'
Sign Up For More News

FAQ

arrow icon

What is Beauty Health Co (SKIN) stock price today?

The current price of SKIN is 1.59 USD — it has decreased -4.22 % in the last trading day.

arrow icon

What is Beauty Health Co (SKIN)'s business?

arrow icon

What is the price predicton of SKIN Stock?

arrow icon

What is Beauty Health Co (SKIN)'s revenue for the last quarter?

arrow icon

What is Beauty Health Co (SKIN)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Beauty Health Co (SKIN)'s fundamentals?

arrow icon

How many employees does Beauty Health Co (SKIN). have?

arrow icon

What is Beauty Health Co (SKIN) market cap?